Low-Dose Instillation Therapy with Bacille Calmette-Guérin Tokyo 172 Strain After Transurethral Resection: Historical Cohort Study
- 30 June 2008
- journal article
- research article
- Published by Elsevier BV in Urology
- Vol. 71 (6), 1161-1165
- https://doi.org/10.1016/j.urology.2007.11.080
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Long‐term follow‐up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette‐Guérin with a reduced dose of 27 mg in superficial bladder cancerBJU International, 2002
- Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success.European Urology, 1998
- Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancerInternational Urology and Nephrology, 1998
- Low Dose Pasteur Bacillus Calmette-Guerin Regimen in Stage T1, Grade 3 Bladder Cancer TherapyJournal of Urology, 1996
- Low‐dose bacille Calmette‐Guerin (BCG) therapy in superficial high‐risk bladder cancer: a phase II study with the BCG strain Connaught CanadaBritish Journal of Urology, 1995
- Improving the Efficacy of BCG Immunotherapy by Dose ReductionEuropean Urology, 1995
- Improving the Safety of BCG Immunotherapy by Dose ReductionEuropean Urology, 1995
- Dose-Response of Bacillus Calmette-Guerin in the Treatment of Superficial Bladder CancerJournal of Urology, 1992
- A Low Dose Bacillus Calmette-Guerin Regimen in Superficial Bladder Cancer Therapy: Is it Effective?Journal of Urology, 1991
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976